Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

OW 2026
OW 2026 15 November 2026

Obesity in Focus: Today's evidence. Tomorrow's possibilities​

Meeting description
Add to Calendar
Sunday, 15 November 2026
18:30 - 18:35
(EST)

Live from the newsroom

Jaime Almandoz
18:35 - 18:46
(EST)

Guideline watch: What's changed for obesity care?

Deborah Bade Horn
18:46 - 18:57
(EST)

Evidence bulletin: Where is the evidence pointing for approved pharmacological options?

Akshay Jain
18:57 - 19:07
(EST)

Expert commentary

Jaime Almandoz, Akshay Jain, Deborah Bade Horn, Domenica Rubino, Thomas Lutz
19:07 - 19:18
(EST)

Science spotlight: What is amylin and its mechanism of action?

Thomas Lutz
19:18 - 19:30
(EST)

Newsflash: The latest on amylin analogs

Domenica Rubino
19:30 - 19:40
(EST)

Expert commentary

Jaime Almandoz, Akshay Jain, Deborah Bade Horn, Domenica Rubino, Thomas Lutz
19:40 - 19:45
(EST)

Today’s headlines

Jaime Almandoz
Keywords
Obesity
Congress industry session
GLP-1 RA
Cagrilintide
CagriSema
Semaglutide
Semaglutide (oral)
PHASE 1 (RCT)
PHASE 2 (RCT)
PHASE 3 (RCT)
Non-clinical
RWE HEOR